Literature DB >> 25120822

Spontaneous regression of breast cancer with axillary lymph node metastasis: a case report and review of literature.

Eriko Tokunaga1, Shinji Okano2, Yuichiro Nakashima3, Nami Yamashita1, Kimihiro Tanaka1, Sauri Akiyoshi1, Kenji Taketani1, Mitsunori Shirouzu4, Hidetaka Yamamoto5, Masaru Morita1, Yoshihiko Maehara1.   

Abstract

Spontaneous regression (SR) of cancer is a rare but well-documented biological phenomenon. However, the mechanism remains to be elucidated. We herein report a case of the SR of breast cancer at both the primary site and metastatic axillary lymph node with spontaneously-induced T cell-mediated immunological responses. A 52-year-old female with a lump in the left axilla was diagnosed to have a small breast carcinoma with a distinct axillary lymph node metastasis. During the preoperative systemic examination, she was diagnosed to have severe type 2 diabetes mellitus, was treated with insulin, and the hyperglycemia was normalized after one month. Surgery for left breast cancer was then performed. The postoperative histopathological examination revealed the SR of breast cancer at both the primary site and metastatic axillary lymph node. Immunohistochemical studies revealed that estrogen receptor positive, AE1/AE3-positive ductal carcinoma completely underwent necrosis associated with extensive infiltration of CD3-positive T cells in the tumor nodule in the lymph node. In addition, primary ductal carcinoma cells also underwent single cell necrosis with infiltration of T cells with lymph follicle-like organization of B cells in the mammary gland. The features were suggestive that the tumor eradication in the metastatic lymph node and regression of the primary ductal carcinoma could be due to host T cell response to the ductal carcinoma. As far as we know it is the first report that shows the spontaneous regression of breast cancer, probably due to the spontaneously-induced T cell response.

Entities:  

Keywords:  Spontaneous regression; T cell response; breast cancer; cancer immunology

Mesh:

Substances:

Year:  2014        PMID: 25120822      PMCID: PMC4129057     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

Review 1.  The spontaneous regression of cancer. A review of cases from 1900 to 1987.

Authors:  G B Challis; H J Stam
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

Review 2.  Spontaneous regression of cancer.

Authors:  R J Papac
Journal:  Cancer Treat Rev       Date:  1996-11       Impact factor: 12.111

Review 3.  Spontaneous regression of cancer and the importance of finding its cause.

Authors:  W H Cole
Journal:  Natl Cancer Inst Monogr       Date:  1976-11

4.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Authors:  Julie R Brahmer; Scott S Tykodi; Laura Q M Chow; Wen-Jen Hwu; Suzanne L Topalian; Patrick Hwu; Charles G Drake; Luis H Camacho; John Kauh; Kunle Odunsi; Henry C Pitot; Omid Hamid; Shailender Bhatia; Renato Martins; Keith Eaton; Shuming Chen; Theresa M Salay; Suresh Alaparthy; Joseph F Grosso; Alan J Korman; Susan M Parker; Shruti Agrawal; Stacie M Goldberg; Drew M Pardoll; Ashok Gupta; Jon M Wigginton
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

5.  Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2.

Authors:  Hitomi Nagayama; Katsuaki Sato; Mariko Morishita; Kaoru Uchimaru; Naoki Oyaizu; Takeshi Inazawa; Tomoko Yamasaki; Makoto Enomoto; Takashi Nakaoka; Tetsuya Nakamura; Taira Maekawa; Akifumi Yamamoto; Shinji Shimada; Toshiaki Saida; Yutaka Kawakami; Shigetaka Asano; Kenzaburo Tani; Tsuneo A Takahashi; Naohide Yamashita
Journal:  Melanoma Res       Date:  2003-10       Impact factor: 3.599

Review 6.  Spontaneous regression of cancer: new insights.

Authors:  B A Stoll
Journal:  Biotherapy       Date:  1992

Review 7.  Efforts to explain spontaneous regression of cancer.

Authors:  W H Cole
Journal:  J Surg Oncol       Date:  1981       Impact factor: 3.454

8.  Spontaneous regression of malignant lymphoma of the breast.

Authors:  Kuniko Iihara; Kazuyoshi Yamaguchi; Yu Nishimura; Takuya Iwasaki; Ken Suzuki; Yasuko Hirabayashi
Journal:  Pathol Int       Date:  2004-07       Impact factor: 2.534

9.  Sudden tumour regression with enhanced natural killer cell accumulation in a patient with stage IV breast cancer.

Authors:  A G Maiche; A Jekunen; P Rissanen; P Virkkunen; J Halavaara; J P Turunen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

Review 10.  Mechanism and biological significance of CD4-mediated cytotoxicity.

Authors:  S Hahn; R Gehri; P Erb
Journal:  Immunol Rev       Date:  1995-08       Impact factor: 12.988

View more
  4 in total

1.  Spontaneous regression of occult breast cancer with axillary lymph node metastasis: A case report.

Authors:  Shin Takayama; Kaishi Satomi; Masayuki Yoshida; Chikashi Watase; Takeshi Murata; Sho Shiino; Kenjiro Jimbo; Akihiko Suto
Journal:  Int J Surg Case Rep       Date:  2019-09-20

2.  Spontaneous regression of breast cancer with immune response: a case report.

Authors:  Masahiro Ohara; Yumiko Koi; Tatsunari Sasada; Keiko Kajitani; Seishi Mizuno; Ai Takata; Atsuko Okamoto; Ikuko Nagata; Mie Sumita; Kaita Imachi; Mayumi Watanabe; Yutaka Daimaru; Shingo Kawamura
Journal:  Surg Case Rep       Date:  2021-01-06

3.  Temporary spontaneous regression of male breast cancer: a case report.

Authors:  Kaoru Katano; Yutaka Yoshimitsu; Takahiro Kyuno; Yusuke Haba; Tsutomu Maeda; Seiko Kitamura
Journal:  Surg Case Rep       Date:  2020-12-07

4.  A Case of Spontaneous Regression of Pulmonary Small Cell Carcinoma.

Authors:  Motoi Ugajin; Hisanori Kani
Journal:  Eur J Case Rep Intern Med       Date:  2019-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.